TD Cowen Lowers Illumina's Price Target to $122, Maintains 'Hold' Rating
Jun 07, 2024 16:54
CST Updated
16:54
Illumina
Diagnostic Product Developer
Gelonghui June 7 | TD Cowen: Downgraded Illumina's target price from $140 to $122, maintaining a "Hold" rating.